We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Galderma Group AG (GALD) CHF0.01

Sell:98.40 CHF Buy:98.72 CHF Change: 1.35 CHF (1.39%)
Market closed |  Prices as at close on 23 December 2024 | Switch to live prices |
Sell:98.40 CHF
Buy:98.72 CHF
Change: 1.35 CHF (1.39%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 23 December 2024 | Switch to live prices |
Sell:98.40 CHF
Buy:98.72 CHF
Change: 1.35 CHF (1.39%)
Market closed |  Prices as at close on 23 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Galderma Group AG is a Switzerland based holding Company, specializing in dermatological treatments and skin care products. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.

Contact details

Address:
Zaehlerweg 10
ZUG
6300
Switzerland
Telephone:
+ ()
Website:
https://www.galderma.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
GALD
ISIN:
CH1335392721
Market cap:
23.41 billion CHF
Shares in issue:
237.57 million
Sector:
Pharmaceuticals
Exchange:
SIX Swiss Exchange
Country:
Switzerland
Currency:
Swiss Franc
Indices:
Swiss All Share Index

Key personnel

  • Flemming Ornskov
    Chief Executive Officer, Executive Director, Head of the Executive Committee
  • Thomas Dittrich
    Chief Financial Officer, Member of the Executive Committee
  • Allison Pinkham
    Chief Human Resource Officer, Member of the Executive Committee
  • Adrian Murphy
    Head of Global Operations, Member of the Executive Committee

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.